Embolization coils are used to treat brain and cardiac aneurysms and other blood-related conditions. They are used as an alternative to surgical embolization to cut the blood supply to the tumor. It is used to treat various types of diseases, such as liver cancer, kidney cancer, aortic artery disorders, neuroendocrine tumors, and peripheral vascular diseases.
Cardiovascular diseases (CVDs) are disorders of the heart and blood vessels and include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and other conditions. Factors such as tobacco use, an unhealthy diet, and physical inactivity increase the risk of heart attacks and strokes. CVDs are the leading cause of death across the globe, and they affect more people than any other disease.
The cardiac aneurysm is majorly caused due to blockages in the aortic artery, the disease is categorized into two diseases according to the site of blockages. The blockages are seen in the chest, or the abdomen also called thoracic aortic aneurysm and abdominal aortic aneurysm respectively. The rise in prevalence of cardiac aneurysms is growing across the world. For instance, to the Society for Vascular Surgery (SVS) it is stated that every year in US 2 million people are diagnosed with an abdominal aortic aneurysm. It is also stated that a rupture abdominal aortic aneurysm is the 15th leading cause of death in the country. It is most commonly seen in the le older than 55 years of age.
In addition, the abdominal aortic aneurysm is majorly based on family history or inheritance. The immediate relative is more prone to getting an abdominal aortic aneurysm. The possibility is that 10 times more likely to develop an abdominal aortic aneurysm. And the person may have some type of aneurysm.
Similarly, In Europe, according to the British Heart Foundation every year 5,000 deaths in the UK are caused due to ruptured aortic aneurysms. These are most common in men of 65 years of age and above and they are responsible for 1 in 75 deaths of men in this age group. Likewise, the similar trend is observed in the other region across the world. Therefore, owing to the rise in the prevalence of the cardiac aneurysm in the regions and in various countries are likely to increase the growth of the embolization coils in the forecast period. Therefore, the rise in the prevalence of cardiac aneurysms is fueling the growth of the embolization coils market
Based on type, the global embolization coils market is segmented into detachable coil and pushable coil. In 2021, the detachable coil segment held a larger market share. Moreover, the same segment is estimated to grow at a significant CAGR during the forecast period. Detachable coils take less time for the procedure than pushable ones and are characterized as soft or standardized coils used for aneurysms and vessels in various clinical applications. The coils are placed with one-click mechanical detachment handle technology.
Based on application, the global embolization coils market is segmented into neurology, cardiology, urology, oncology, peripheral vascular disease, and other. In 2021, the neurology segment held the largest share of the market. Moreover, the same segment is expected to grow at the fastest rate in the coming years. Embolization coils are generally used to treat brain aneurysms and arteriovenous malformations (AVMs) in the field of neurology. An AVM is a tangle of blood vessels connecting arteries and veins that disrupts blood flow and oxygen circulation, resulting in the lack of oxygen for surrounding tissues.
Based on material, the global embolization coils market is segmented into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest share of the market in 2021. Moreover, the same segment is expected to register the highest CAGR from 2022 to 2028.
Based on end user, the global embolization coils market is segmented into hospital, cardiac center, ambulatory center, and other. The hospital segment held the largest share of the market in 2021. Moreover, the same segment is expected to register the highest CAGR from 2022 to 2028.
Inorganic developments such as mergers and acquisitions are highly adopted strategies by companies in the global embolization coils market. A few of the recent key market developments are listed below:
The regional trends and factors influencing the Embolization Coils Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Embolization Coils Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1.19 Billion |
| Market Size by 2028 | US$ 1.59 Billion |
| Global CAGR (2021 - 2028) | 4.3% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Embolization Coils Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Embolization Coils Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The Asia Pacific is expected to be the fastest-growing region in the embolization market over the forecast period due to growing investments from international players in China and India, increasing disposable income, and lifestyle diseases in these regions will show promising growth in the embolization market.
The embolization coil market is estimated to be valued at US$ 1,191.78 million in 2021.
The embolization coil market is expected to be valued at US$ 1,591.60 million in 2028.
The detachable coil held the largest share of the market in the global embolization coil market contributing a market share of US$ 686.47 million in 2021.
The CAGR value of the embolization coil market during the forecasted period of 2022-2028 is 4.3%.
The embolization coil market majorly consists of the players, such as Terumo Corporation; Medtronic; Boston Scientific Corporation; Stryker Corporation; Johnson & Johnson; Cook Medical; Penumbra, Inc; Kaneka Corporation; Shape Memory Medical INC; and Microport Scientific Corporation
The number of minimally invasive surgeries is rising as patients increasingly prefer such surgeries due to lesser postoperative pain, postoperative complications, shorter hospital stays, fast recovery times, etc. Noninvasive or minimally invasive treatments are being developed as alternatives to surgery for patients with early-stage breast cancer. For instance, Trans Arterial Chemo Embolization, also known as TACE, is a minimally invasive procedure that is typically used to treat hepatocellular carcinoma
Coil embolization describes a minimally invasive surgical procedure for the treatment of cerebral aneurysms and fistulas. A tiny coil is passed to the brain through a catheter inserted in the groin and disconnected from the catheter to prevent blood flow to the aneurysm or fistula. One or more platinum coils are left in place to prevent the aneurysm from rupturing. Reduced blood flow to the brain can impair binocular vision.